Akcea and Ionis’ familial chylomicronaemia syndrome study a success
23 March 2017 | By Niamh Marriott, Junior Editor
Akcea Therapeutics' pivotal Phase 3 study of volanesorsen reduced triglyceride levels in patients with familial chylomicronaemia syndrome...